Gut Microbiomes in HD

Part of paid clinical trials in Orlando, Florida.

Sponsor
University of Central Florida
Study ID
NCT06448546
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

The purpose of this study is to find out if there is a connection between the naturally occurring bacteria in our bodies and the progression of Huntington disease. The investigators are trying to determine if patients who are diagnosed with adult-onset HD and who exhibit a rapid rate of disease progression have unique populations of bacteria in their gut as compared to patients with slower progression.

Key Dates

Start date
Jun 30, 2025
Status verified
Jun 2025
Primary completion
Jun 30, 2027
Completion
Jun 30, 2029

Study Design

Enrollment
36 participants (estimated)

Arms

  • Arm: Control
    Patients who are not diagnosed with HD
  • Arm: Experimental Group 1
    Underweight HD patients
  • Arm: Experimental Group 2
    Overweight HD patients

Primary Outcome Measure

To quantify relative abundance of entire gut microbiomes in people using Metagenomic analysis [ Time Frame: 5 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Central FloridaOrlandoFlorida32816
Amoy Fraser, PhD, CCRP, PMP
[email protected]
4072668742
Erica Martin, BS
[email protected]
4072668742

Find similar trials in Orlando, FL

By condition
Huntington disease
By specialty
NeurologyBrain disorders
By research site
University of Central Florida· Orlando, FL

Related Studies